Smith-Palmer J, Leeuwenkamp OR, Virk J, Reed N, et al. Lutetium oxodotreotide ((177)Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland. BMC Cancer 2021;21:10.
PMID: 33402120